Biologic Development and Biomanufacturing Services

  • At VxP, we work with global pharma and biotech companies who are developing vaccines, or who are looking for viral vectors. We work with multiple existing cell lines that are pre-qualified, so our clients are not required to provide their own cell line. This is a huge cost savings and can also reduce development time. We are also able to transfer in your cell line if that is your preference.
  • Our expertise is in developing and manufacturing of viral vaccines, viral vectors for gene and immunotherapeutics, as well as oncolytic viruses, virus-like particles, and other biologics. We have GMP manufacturing facilities in Europe and the United States, offering capabilities from early-stage development through clinical to commercial scale. In Drug Substance Manufacturing, we provide master / working cell banks, master / working virus seeds, manufacture of bulk drug substance, and multiple manufacturing platforms. Working with our clients, we have been involved in the development and GMP manufacture of many of the world’s most notable vaccines developed over the last two decades.
  • Upstream and Downstream Processing:
    1. VxP offers multiple cell culture techniques for manufacturing live viruses to optimize production/virus yields. We also have have extensive experience developing downstream purification processes for recombinant proteins and viruses.



VxP Pharma, Inc.

  • 317.759.2299
  • Purdue Research Park
    5225 Exploration Drive
    Indianapolis, IN 46241